Publications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (13)

2022

  1. Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer

    International Journal of Gynecological Cancer, Vol. 32, Núm. 8, pp. 1009-1016

2021

  1. Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

    Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337

2019

  1. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899

2018

  1. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

2017

  1. 18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: A window-of-opportunity randomized trial

    Clinical Cancer Research, Vol. 23, Núm. 6, pp. 1432-1441

  2. Critically short telomeres and toxicity of chemotherapy in early breast cancer

    Oncotarget, Vol. 8, Núm. 13, pp. 21472-21482

2014

  1. Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

    British journal of cancer, Vol. 111, Núm. 6, pp. 1060-1064

  2. Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial

    Molecular Oncology, Vol. 8, Núm. 8, pp. 1719-1728

2013

  1. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC

    International Journal of Cancer, Vol. 132, Núm. 9, pp. 1986-1995

2009

  1. A gene-alteration profile of human lung cancer cell lines

    Human Mutation, Vol. 30, Núm. 8, pp. 1199-1206

2008

  1. Frequent BRG1/SMARCA4-Inactivating mutations in human lung cancer cell lines

    Human Mutation, Vol. 29, Núm. 5, pp. 617-622

2007

  1. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway

    Neoplasia, Vol. 9, Núm. 10, pp. 840-852

2004

  1. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene

    Oncogene, Vol. 23, Núm. 22, pp. 4037-4040